{"slug":"semaglutide-gut","verification":{"valid":true,"entries":2,"head":"09d1a6a122bc9c26c8524053511bcafd6e6ab960af2bd6bfa2eed75bf0225e4a"},"energy":{"passes":2,"tokens_in":14696,"tokens_out":3280,"tokens_total":17976,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"09d1a6a122bc9c26c8524053511bcafd6e6ab960af2bd6bfa2eed75bf0225e4a"},"provenance":[{"ts":"2026-06-30T00:26:42.983Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Semaglutide for Gut\nSlug: semaglutide-gut\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"semaglutide\",\"name\":\"Semaglutide\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"semaglutide\",\"name\":\"Semaglutide\",\"section_title\":\"Why Semaglutide might help you\",\"layer\":\"metabolic load / body weight\",\"steps\":[\"**What keeps failing:** Weight-related joint and disc overload; metabolic stress on repair capacity.\",\"**What Semaglutide is studied to do:** Studied for GLP-1-driven weight loss — reduces mechanical load on weight-sensitive tissues.\",\"**Therefore for you:** If that layer is part of your problem, Semaglutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Weight-related joint and disc overload; metabolic stress on repair capacity.\\n2. **What Semaglutide is studied to do:** Studied for GLP-1-driven weight loss — reduces mechanical load on weight-sensitive tissues.\\n3. **Therefore for you:** If that layer is part of your problem, Semaglutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus ","response":"{\n  \"slug\": \"semaglutide-gut\",\n  \"title\": \"Semaglutide for Gut: Evidence on Microbiota, Barrier Function, and Motility\",\n  \"body\": \"## What's breaking down\\n\\nGut health involves layers of microbial balance, intestinal barrier integrity, motility control, and low-grade inflammation. When these layers degrade faster than they repair, issues like dysbiosis, increased permeability, slowed or erratic emptying, and systemic metabolic stress can persist. Weight excess adds another layer by altering bile acids, short-chain fatty acid production, and overall gut signaling. Semaglutide is discussed here in the context of these layers rather than symptom masking.\\n\\n## Why Semaglutide might help you\\n\\n1. **What keeps failing:** Weight-related metabolic stress on gut repair capacity; shifts in microbiota that favor inflammation over short-chain fatty acid production; delayed or disordered motility from GLP-1 signaling changes.\\n2. **What Semaglutide is studied to do:** Studied for GLP-1-driven weight loss and direct receptor effects on gastric emptying, bile acid metabolism, and microbial composition shifts.\\n3. **Therefore for you:** If metabolic load or microbiota imbalance forms part of your gut picture, Semaglutide is discussed because it targets those upstream repair pathways — not because it simply slows transit or suppresses appetite signals.\\n\\n## How these fit together\\n\\nSingle-compound focus. Semaglutide maps primarily to metabolic load and body weight layers. If your profile includes multi-peptide stacks, other compounds would target separate degeneration layers such as direct neural repair or inflammation suppression.\\n\\n## What the evidence actually shows\\n\\nHuman data remain limited. A 2025 study in 15 Chinese patients with type 2 diabetes on metformin found semaglutide altered gut microbiota diversity and community structure alongside glycemic and weight improvements (source from pubmed.ncbi.nlm.nih.gov/41132642). Another small trial in people with HIV (SLIM L","tokens_in":14696,"tokens_out":3280,"cost":0,"prev":"genesis","hash":"8c943bfd37a107212ad7f1a53e2ec27ec5340e7b2857f37a322c8918ebb1b879"},{"ts":"2026-07-17T02:41:45.913Z","model":"owner","action":"voxel_divide","prompt":"","input":"semaglutide-gut","response":"20 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"8c943bfd37a107212ad7f1a53e2ec27ec5340e7b2857f37a322c8918ebb1b879","hash":"09d1a6a122bc9c26c8524053511bcafd6e6ab960af2bd6bfa2eed75bf0225e4a"}]}